Strategies for improving the 3D printability of decellularized extracellular matrix bioink

Theranostics. 2023 Apr 23;13(8):2562-2587. doi: 10.7150/thno.81785. eCollection 2023.


3D bioprinting is a revolutionary technology capable of replicating native tissue and organ microenvironments by precisely placing cells into 3D structures using bioinks. However, acquiring the ideal bioink to manufacture biomimetic constructs is challenging. A natural extracellular matrix (ECM) is an organ-specific material that provides physical, chemical, biological, and mechanical cues that are hard to mimic using a small number of components. Organ-derived decellularized ECM (dECM) bioink is revolutionary and has optimal biomimetic properties. However, dECM is always “non-printable” owing to its poor mechanical properties. Recent studies have focused on strategies to improve the 3D printability of dECM bioink. In this review, we highlight the decellularization methods and procedures used to produce these bioinks, effective methods to improve their printability, and recent advances in tissue regeneration using dECM-based bioinks. Finally, we discuss the challenges associated with manufacturing dECM bioinks and their potential large-scale applications.

PMID:37215563 | PMC:PMC10196833 | DOI:10.7150/thno.81785


Related Posts

Leave a Reply

Your email address will not be published. Required fields are marked *

Generated by Feedzy